Bacterial toxin and effector glycosyltransferases

Biochimica et Biophysica Acta - General Subjects

Volumn 1800, Issue 2, 2010, Pages 134-143

  Belyi, Yury ^a   Aktories, Klaus ^b  

^a GAMALEYA RESEARCH INSTITUTE OF EPIDEMIOLOGY AND MICROBIOLOGY   (Russian Federation)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Bacterial protein toxin; Clostridial glucosylating toxin; Clostridium difficile toxin; Elongation factor 1A; Glucosylation; Glycosyltransferase; Legionella pneumophila; Rho protein

Indexed keywords

BACTERIAL TOXIN; CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B; CYTOTOXIN; ELONGATION FACTOR 1ALPHA; GLYCOSYLTRANSFERASE; RAS PROTEIN; RHO FACTOR; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; SERINE; THREONINE; VIRULENCE FACTOR;

BACTERIAL VIRULENCE; CATALYSIS; CLOSTRIDIUM; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM NOVYI; CLOSTRIDIUM SORDELLII; CYTOLOGY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME MECHANISM; ENZYME SPECIFICITY; ENZYME STRUCTURE; ENZYME SUBSTRATE; GLYCOSYLATION; LEGIONELLA PNEUMOPHILA; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; REVIEW; TARGET CELL; TOXIN ANALYSIS; TOXIN STRUCTURE;

AMINO ACID SEQUENCE; BACTERIAL TOXINS; GLYCOSYLTRANSFERASES; HUMANS; LEGIONELLA PNEUMOPHILA; MOLECULAR SEQUENCE DATA; PEPTIDE ELONGATION FACTOR 1; PROTEIN CONFORMATION; PROTEIN STRUCTURE, TERTIARY; RAS PROTEINS; SEQUENCE ALIGNMENT; SUBSTRATE SPECIFICITY; TRANSCRIPTION FACTORS; VIRULENCE FACTORS;

BACTERIA (MICROORGANISMS); CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM NOVYI; CLOSTRIDIUM SORDELLII; LEGIONELLA; LEGIONELLA PNEUMOPHILA;

EID: 77949284319     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2009.07.022     Document Type: Review

References (118)

1. Abel K., Yoder M.D., Hilgenfeld R., and Jurnak F. An alpha to beta conformational switch in EF-Tu. Structure 4 (1996) 1153-1159
2. Amimoto K., Noro T., Oishi E., and Shimizu M. A novel toxin homologous to large clostridial cytotoxins found in culture supernatant of Clostridium perfringens type C. Microbiology 153 (2007) 1198-1206
3. Andersen G.R., Pedersen L., Valente L., Chatterjee I., Kinzy T.G., Kjeldgaard M., and Nyborg J. Structural basis for nucleotide exchange and competition with tRNA in the yeast elongation factor complex eEF1A:eEF1Balpha. Mol. Cell 6 (2000) 1261-1266
4. Babbin B.A., Sasaki M., Gerner-Schmidt K.W., Nusrat A., and Klapproth J.M. The bacterial virulence factor lymphostatin compromises intestinal epithelial barrier function by modulating rho GTPases. Am. J. Pathol. 174 (2009) 1347-1357
5. Banga S., Gao P., Shen X., Fiscus V., Zong W.X., Chen L., and Luo Z.Q. Legionella pneumophila inhibits macrophage apoptosis by targeting pro-death members of the Bcl2 protein family. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 5121-5126
6. Barth H., Pfeifer G., Hofmann F., Maier E., Benz R., and Aktories K. Low pH-induced formation of ion channels by Clostridium difficile toxin B in target cells. J. Biol. Chem. 276 (2001) 10670-10676
7. Bartlett J.G. Historical perspectives on studies of Clostridium difficile and C. difficile infection. Clin. Infect. Dis. 46 Suppl 1 (2008) S4-S11
8. Bartlett J.G., Onderdonk A.B., Cisneros R.L., and Kasper D.L. Clindamycin-associated colitis due to a toxin-producing species of Clostridium in hamsters. J. Infect. Dis. 136 (1977) 701-705
9. Belyi I., Popoff M.R., and Cianciotto N.P. Purification and characterization of a UDP-glucosyltransferase produced by Legionella pneumophila. Infect. Immun. 71 (2003) 181-186
10. Belyi Y., Niggeweg R., Opitz B., Vogelsgesang M., Hippenstiel S., Wilm M., and Aktories K. Legionella pneumophila glucosyltransferase inhibits host elongation factor 1A. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 16953-16958
11. Belyi Y., Stahl M., Sovkova I., Kaden P., Luy B., and Aktories K. Region of elongation factor 1A1 involved in substrate recognition by Legionella pneumophila glucosyltransferase LGT1-identification of LGT1 as a retaining glucosyltransferase. J. Biol. Chem. 284 (2009) 20167-20174
12. Belyi Y., Tabakova I., Stahl M., and Aktories K. Lgt: a family of cytotoxic glucosyltransferases produced by Legionella pneumophila. J. Bacteriol. 190 (2008) 3026-3035
13. Boriello S.P., and Aktories K. Clostridium perfringens, Clostridium difficile and other Clostridium species. In: Boriello S.P., Murray P.R., and Funke G. (Eds). Topley and Wilson's Microbiology and Microbial Infections, vol. Bacteriology (2005), Edward Arnold 1089-1136
14. Borradaile N.M., Buhman K.K., Listenberger L.L., Magee C.J., Morimoto E.T., Ory D.S., and Schaffer J.E. A critical role for eukaryotic elongation factor 1A-1 in lipotoxic cell death. Mol. Biol. Cell (2005)
15. Breton C., Snajdrova L., Jeanneau C., Koca J., and Imberty A. Structures and mechanisms of glycosyltransferases. Glycobiology 16 (2006) 29R-37R
16. Bruggemann H., Hagman A., Jules M., Sismeiro O., Dillies M.A., Gouyette C., Kunst F., Steinert M., Heuner K., Coppee J.Y., and Buchrieser C. Virulence strategies for infecting phagocytes deduced from the in vivo transcriptional program of Legionella pneumophila. Cell. Microbiol. 8 (2006) 1228-1240
17. Burridge K., and Wennerberg K. Rho and Rac take center stage. Cell 116 (2004) 167-179
18. Busch C., and Aktories K. Microbial toxins and the glucosylation of Rho family GTPases. Curr. Opin. Struct. Biol. 10 (2000) 528-535
19. Busch C., Hofmann F., Selzer J., Munro J., Jeckel D., and Aktories K. A common motif of eukaryotic glycosyltransferases is essential for the enzyme activity of large clostridial cytotoxins. J. Biol. Chem. 273 (1998) 19566-19572
20. Byrne B., and Swanson M.S. Expression of Legionella pneumophila virulence traits in response to growth conditions. Infect. Immun. 66 (1998) 3029-3034
21. Carlson J.H., Hughes S., Hogan D., Cieplak G., Sturdevant D.E., McClarty G., Caldwell H.D., and Belland R.J. Polymorphisms in the Chlamydia trachomatis cytotoxin locus associated with ocular and genital isolates. Infect. Immun. 72 (2004) 7063-7072
22. Chuang S.M., Chen L., Lambertson D., Anand M., Kinzy T.G., and Madura K. Proteasome-mediated degradation of cotranslationally damaged proteins involves translation elongation factor 1A. Mol. Cell Biol. 25 (2005) 403-413
23. Clark G.F., Krivan H.C., Wilkins T.D., and Smith D.F. Toxin A from Clostridium difficile binds to rabbit erythrocyte glycolipids with terminal Gal alpha 1-3Gal beta 1-4GlcNAc sequences. Arch. Biochem. Biophys. 257 (1987) 217-229
24. Coers J., Monahan C., and Roy C.R. Modulation of phagosome biogenesis by Legionella pneumophila creates an organelle permissive for intracellular growth. Nat. Cell Biol. 1 (1999) 451-453
25. Cohen A.L., Bhatnagar J., Reagan S., Zane S.B., D'Angeli M.A., Fischer M., Killgore G., Kwan-Gett T.S., Blossom D.B., Shieh W.J., Guarner J., Jernigan J., Duchin J.S., Zaki S.R., and McDonald L.C. Toxic shock associated with Clostridium sordellii and Clostridium perfringens after medical and spontaneous abortion. Obstet. Gynecol. 110 (2007) 1027-1033
26. de Felipe K.S., Glover R.T., Charpentier X., Anderson O.R., Reyes M., Pericone C.D., and Shuman H.A. Legionella eukaryotic-like type IV substrates interfere with organelle trafficking. PLoS Pathog. 4 (2008) e1000117
27. de Felipe K.S., Pampou S., Jovanovic O.S., Pericone C.D., Ye S.F., Kalachikov S., and Shuman H.A. Evidence for acquisition of Legionella type IV secretion substrates via interdomain horizontal gene transfer. J. Bacteriol. 187 (2005) 7716-7726
28. Derre I., and Isberg R.R. Legionella pneumophila replication vacuole formation involves rapid recruitment of proteins of the early secretory system. Infect. Immun. 72 (2004) 3048-3053
29. Dever T.E., Costello C.E., Owens C.L., Rosenberry T.L., and Merrick W.C. Location of seven post-translational modifications in rabbit elongation factor 1 alpha including dimethyllysine, trimethyllysine, and glycerylphosphorylethanolamine. J. Biol. Chem. 264 (1989) 20518-20525
30. Diederen B.M. Legionella spp. and Legionnaires' disease. J. Infect. 56 (2008) 1-12
31. Dreger S.C., Schulz F., Huelsenbeck J., Gerhard R., Hofmann F., Just I., and Genth H. Killing of rat basophilic leukemia cells by lethal toxin from Clostridium sordellii: critical role of phosphatidylinositide 3′-OH kinase/Akt signaling. Biochemistry (Febraury 6 2009) Electronic publication ahead of print
32. Egerer M., Giesemann T., Herrmann C., and Aktories K. Autocatalytic processing of Clostridium difficile toxin B. Binding of inositol hexakisphosphate. J. Biol. Chem. 284 (2009) 3389-3395
33. Egerer M., Giesemann T., Jank T., Satchell K.J., and Aktories K. Auto-catalytic cleavage of Clostridium difficile toxins A and B depends on a cysteine protease activity. J. Biol. Chem. 282 (2007) 25314-25321
34. Ejiri S. Moonlighting functions of polypeptide elongation factor 1: from actin bundling to zinc finger protein R1-associated nuclear localization. Biosci. Biotechnol. Biochem. 66 (2002) 1-21
35. Etienne-Manneville S., and Hall A. Rho GTPases in cell biology. Nature 420 (2002) 629-635
36. Fields B.S., Benson R.F., and Besser R.E. Legionella and Legionnaires' disease: 25 years of investigation. Clin. Microbiol. Rev. 15 (2002) 506-526
37. Florin I., and Thelestam M. Internalization of Clostridium difficile cytotoxin into cultured human lung fibroblasts. Biochim. Biophys. Acta 763 (1983) 383-392
38. Frey S.M., and Wilkins T.D. Localization of two epitopes recognized by monoclonal antibody PCG-4 on Clostridium difficile toxin A. Infect. Immun. 60 (1992) 2488-2492
39. Frisch C., Gerhard R., Aktories K., Hofmann F., and Just I. The complete receptor-binding domain of Clostridium difficile toxin A is required for endocytosis. Biochem. Biophys. Res. Commun. 300 (2003) 706-711
40. Genth H., Aktories K., and Just I. Monoglucosylation of RhoA at threonine-37 blocks cytosol-membrane cycling. J. Biol. Chem. 274 (1999) 29050-29056
41. Genth H., Dreger S.C., Huelsenbeck J., and Just I. Clostridium difficile toxins: more than mere inhibitors of Rho proteins. Int. J. Biochem. Cell Biol. 40 (2008) 592-597
42. Geyer M., Wilde C., Selzer J., Aktories K., and Kalbitzer H.R. Glucosylation of Ras by Clostridium sordellii lethal toxin: consequences for the effector loop conformations observed by NMR spectroscopy. Biochemistry 42 (2003) 11951-11959
43. Giesemann T., Jank T., Gerhard R., Maier E., Just I., Benz R., and Aktories K. Cholesterol-dependent pore formation of Clostridium difficile toxin A. J. Biol. Chem. 281 (2006) 10808-10815
44. Greco A., Ho J.G., Lin S.J., Palcic M.M., Rupnik M., and Ng K.K. Carbohydrate recognition by Clostridium difficile toxin A. Nat. Struct. Mol. Biol. 13 (2006) 460-461
45. Gross S.R., and Kinzy T.G. Translation elongation factor 1A is essential for regulation of the actin cytoskeleton and cell morphology. Nat. Struct. Mol. Biol. 12 (2005) 772-778
46. Gruenheid S., and Finlay B.B. Microbial pathogenesis and cytoskeletal function. Nature 422 (2003) 775-781
47. Halabi-Cabezon I., Huelsenbeck J., May M., Ladwein M., Rottner K., Just I., and Genth H. Prevention of the cytopathic effect induced by Clostridium difficile toxin B by active Rac1. FEBS Lett. 582 (2008) 3751-3756
48. Heasman S.J., and Ridley A.J. Mammalian Rho GTPases: new insights into their functions from in vivo studies. Nat. Rev. Mol. Cell Biol. 9 (2008) 690-701
49. Heidtman M., Chen E.J., Moy M.Y., and Isberg R.R. Large-scale identification of Legionella pneumophila Dot/Icm substrates that modulate host cell vesicle trafficking pathways. Cell. Microbiol. 11 (2009) 230-248
50. Ho J.G., Greco A., Rupnik M., and Ng K.K. Crystal structure of receptor-binding C-terminal repeats from Clostridium difficile toxin A. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 18373-18378
51. Horwitz M.A. The Legionnaires' disease bacterium (Legionella pneumophila) inhibits phagosome-lysosome fusion in human monocytes. J. Exp. Med. 158 (1983) 2108-2126
52. Horwitz M.A., and Maxfield F.R. Legionella pneumophila inhibits acidification of its phagosome in human monocytes. J. Cell Biol. 99 (1984) 1936-1943
53. Hotokezaka Y., Tobben U., Hotokezaka H., Van L.K., Beatrix B., Smith D.H., Nakamura T., and Wiedmann M. Interaction of the eukaryotic elongation factor 1A with newly synthesized polypeptides. J. Biol. Chem. 277 (2002) 18545-18551
54. Huelsenbeck J., Dreger S., Gerhard R., Barth H., Just I., and Genth H. Difference in the cytotoxic effects of toxin B from Clostridium difficile strain VPI 10463 and toxin B from variant Clostridium difficile strain 1470. Infect. Immun. 75 (2007) 801-809
55. Ingmundson A., Delprato A., Lambright D.G., and Roy C.R. Legionella pneumophila proteins that regulate Rab1 membrane cycling. Nature 450 (2007) 365-369
56. Isberg R.R., O'Connor T.J., and Heidtman M. The Legionella pneumophila replication vacuole: making a cosy niche inside host cells. Nat. Rev. Microbiol. 7 (2009) 13-24
57. Jaffe A.B., and Hall A. Rho GTPases: biochemistry and biology. Annu. Rev. Cell Dev. Biol. 21 (2005) 247-269
58. Jank T., and Aktories K. Structure and mode of action of clostridial glucosylating toxins: the ABCD model. Trends Microbiol. 16 (2008) 222-229
59. Jank T., Giesemann T., and Aktories K. Clostridium difficile glucosyltransferase toxin B - essential amino acids for substrate-binding. J. Biol. Chem. 282 (2007) 35222-35231
60. Jank T., Giesemann T., and Aktories K. Rho-glucosylating Clostridium difficile toxins A and B: new insights into structure and function. Glycobiology 17 (2007) 15R-22R
61. Jank T., Reinert D.J., Giesemann T., Schulz G.E., and Aktories K. Change of the donor substrate specificity of Clostridium difficile toxin B by site-directed mutagenesis. J. Biol. Chem. 280 (2005) 37833-37838
62. Just I., and Gerhard R. Large clostridial cytotoxins. Rev. Physiol. Biochem. Pharmacol. 152 (2004) 23-47
63. Just I., Selzer J., Hofmann F., Green G.A., and Aktories K. Inactivation of Ras by Clostridium sordellii lethal toxin-catalyzed glucosylation. J. Biol. Chem. 271 (1996) 10149-10153
64. Just I., Selzer J., Wilm M., Von Eichel-Streiber C., Mann M., and Aktories K. Glucosylation of Rho proteins by Clostridium difficile toxin B. Nature 375 (1995) 500-503
65. Just I., Wilm M., Selzer J., Rex G., Von Eichel-Streiber C., Mann M., and Aktories K. The enterotoxin from Clostridium difficile (ToxA) monoglucosylates the Rho proteins. J. Biol. Chem. 270 (1995) 13932-13936
66. Kagan J.C., and Roy C.R. Legionella phagosomes intercept vesicular traffic from endoplasmic reticulum exit sites. Nat. Cell Biol. 4 (2002) 945-954
67. Kelly C.P., and LaMont J.T. Clostridium difficile - more difficult than ever. N. Engl. J. Med. 359 (2008) 1932-1940
68. Kimura A.C., Higa J.I., Levin R.M., Simpson G., Vargas Y., and Vugia D.J. Outbreak of necrotizing fasciitis due to Clostridium sordellii among black-tar heroin users. Clin. Infect. Dis. 38 (2004) e87-e91
69. Kjeldgaard M., Nyborg J., and Clark B.F.C. The GTP binding motif: variations on a theme. FASEB J. 10 (1996) 1347-1368
70. Klapproth J.M., Donnenberg M.S., Abraham J.M., Mobley H.L., and James S.P. Products of enteropathogenic Escherichia coli inhibit lymphocyte activation and lymphokine production. Infect. Immun. 63 (1995) 2248-2254
71. Krivan H.C., Clark G.F., Smith D.F., and Wilkins T.D. Cell surface binding site for Clostridium difficile enterotoxin: evidence for a glycoconjugate containing the sequence Galα1-3Galβ1-4GlcNAc. Infect. Immun. 53 (1986) 573-581
72. Kubori T., Hyakutake A., and Nagai H. Legionella translocates an E3 ubiquitin ligase that has multiple U-boxes with distinct functions. Mol. Microbiol. 67 (2008) 1307-1319
73. Lairson L.L., Henrissat B., Davies G.J., and Withers S.G. Glycosyltransferases: structures, functions, and mechanisms. Annu. Rev. Biochem. 77 (2008) 521-555
74. Losick V.P., and Isberg R.R. NF-kappaB translocation prevents host cell death after low-dose challenge by Legionella pneumophila. J. Exp. Med. 203 (2006) 2177-2189
75. Lyerly D.M., Saum K.E., MacDonald D.K., and Wilkins T.D. Effects of Clostridium difficile toxins given intragastrically to animals. Infect. Immun. 47 (1985) 349-352
76. Lyras D., O'Connor J.R., Howarth P.M., Sambol S.P., Carter G.P., Phumoonna T., Poon R., Adams V., Vedantam G., Johnson S., Gerding D.N., and Rood J.I. Toxin B is essential for virulence of Clostridium difficile. Nature 458 (2009) 1176-1179
77. Machner M.P., and Isberg R.R. A bifunctional bacterial protein links GDI displacement to Rab1 activation. Science 318 (2007) 974-977
78. McCusker K.T., Braaten B.A., Cho M.W., and Low D.A. Legionella pneumophila inhibits protein synthesis in Chinese hamster ovary cells. Infect. Immun. 59 (1991) 240-246
79. McDonald L.C., Killgore G.E., Thompson A., Owens Jr. R.C., Kazakova S.V., Sambol S.P., Johnson S., and Gerding D.N. An epidemic, toxin gene-variant strain of Clostridium difficile. N. Engl. J. Med. 353 (2005) 2433-2441
80. Mesmin B., Robbe K., Geny B., Luton F., Brandolin G., Popoff M.R., and Antonny B. A phosphatidylserine-binding site in the cytosolic fragment of Clostridium sordellii lethal toxin facilitates glucosylation of membrane-bound Rac and is required for cytotoxicity. J. Biol. Chem. 279 (2004) 49876-49882
81. Na X., Kim H., Moyer M.P., Pothoulakis C., and LaMont J.T. gp96 is a human colonocyte plasma membrane binding protein for Clostridium difficile toxin A. Infect. Immun. 76 (2008) 2862-2871
82. Nagai H., Kagan J.C., Zhu X., Kahn R.A., and Roy C.R. A bacterial guanine nucleotide exchange factor activates ARF on Legionella phagosomes. Science 295 (2002) 679-682
83. Ninio S., and Roy C.R. Effector proteins translocated by Legionella pneumophila: strength in numbers. Trends Microbiol. 15 (2007) 372-380
84. Pfeifer G., Schirmer J., Leemhuis J., Busch C., Meyer D.K., Aktories K., and Barth H. Cellular uptake of Clostridium difficile toxin B: translocation of the N-terminal catalytic domain into the cytosol of eukaryotic cells. J. Biol. Chem. 278 (2003) 44535-44541
85. Popoff M.R., Chaves O.E., Lemichez E., Von Eichel-Streiber C., Thelestam M., Chardin P., Cussac D., Chavrier P., Flatau G., Giry M., Gunzburg J., and Boquet P. Ras, Rap, and Rac small GTP-binding proteins are targets for Clostridium sordellii lethal toxin glucosylation. J. Biol. Chem. 271 (1996) 10217-10224
86. Pothoulakis C., Gilbert R.J., Cladaras C., Castagliuolo I., Semenza G., Hitti Y., Montcrief J.S., Linevsky J., Kelly C.P., Nikulasson S., Desai H.P., Wilkins T.D., and LaMont J.T. Rabbit sucrase-isomaltase contains a functional intestinal receptor for Clostridium difficile toxin A. J. Clin. Invest. 98 (1996) 641-649
87. Qa'Dan M., Spyres L.M., and Ballard J.D. pH-induced conformational changes in Clostridium difficile toxin B. Infect. Immun. 68 (2000) 2470-2474
88. Ramakrishnan V. Ribosome structure and the mechanism of translation. Cell 108 (2002) 557-572
89. Reineke J., Tenzer S., Rupnik M., Koschinski A., Hasselmayer O., Schrattenholz A., Schild H., and Von Eichel-Streiber C. Autocatalytic cleavage of Clostridium difficile toxin B. Nature 446 (2007) 415-419
90. Reinert D.J., Jank T., Aktories K., and Schulz G.E. Structural basis for the function of Clostridium difficile toxin B. J. Mol. Biol. 351 (2005) 973-981
91. Riegler M., Sedivy R., Pothoulakis C., Hamilton G., Zacheri J., Bischof G., Cosentini E., Feil W., Schiessel R., LaMont J.T., and Wenzl E. Clostridium difficile toxin B is more potent than toxin A in damaging human colonic epithelium in vitro. J. Clin. Invest. 95 (1995) 2004-2011
92. Rupnik M., Avesani V., Janc M., Von Eichel-Streiber C., and Delmée M. A novel toxinotyping scheme and correlation of toxinotypes with serogroups of Clostridium difficile isolates. J. Clin. Microbiol. 36 (1998) 2240-2247
93. Rupnik M., Braun V., Soehn F., Janc M., Hofstetter M., Laufenberg-Feldmann R., and Von Eichel-Streiber C. Characterization of polymorphisms in the toxin A and B genes of Clostridium difficile. FEMS Microbiol. Lett. 148 (1997) 197-202
94. Rupnik M., Pabst S., Rupnik M., Von Eichel-Streiber C., Urlaub H., and Soling H.D. Characterization of the cleavage site and function of resulting cleavage fragments after limited proteolysis of Clostridium difficile toxin B (TcdB) by host cells. Microbiology 151 (2005) 199-208
95. Samlaska C.P., and Maggio K.L. Subcutaneous emphysema. Adv. Dermatol. 11 (1996) 117-151
96. Santic M., Asare R., Doric M., and Abu K.Y. Host-dependent trigger of caspases and apoptosis by Legionella pneumophila. Infect. Immun. 75 (2007) 2903-2913
97. Schirmer J., and Aktories K. Large clostridial cytotoxins: cellular biology of Rho/Ras-glucosylating toxins. Biochim. Biophys. Acta 1673 (2004) 66-74
98. Sehr P., Joseph G., Genth H., Just I., Pick E., and Aktories K. Glucosylation and ADP-ribosylation of Rho proteins - Effects on nucleotide binding, GTPase activity, and effector-coupling. Biochemistry 37 (1998) 5296-5304
99. Selzer J., Hofmann F., Rex G., Wilm M., Mann M., Just I., and Aktories K. Clostridium novyi α-toxin-catalyzed incorporation of GlcNAc into Rho subfamily proteins. J. Biol. Chem. 271 (1996) 25173-25177
100. Selzer J., Hofmann F., Rex G., Wilm M., Mann M., Just I., and Aktories K. Clostridium novyi α-toxin-catalyzed incorporation of GlcNAc into Rho subfamily proteins. J. Biol. Chem. 271 (1996) 25173-25177
101. Smedley III J.G., Fisher D.J., Sayeed S., Chakrabarti G., and McClane B.A. The enteric toxins of Clostridium perfringens. Rev. Physiol. Biochem. Pharmacol. 152 (2004) 183-204
102. Stubbe H., Berdoz J., Kraehenbuhl J.-P., and Corthésy B. Polymeric IgA is superior to monomeric IgA and IgG carrying the same variable domain in preventing Clostridium difficile toxin A damaging of T84 monolayers. J. Immunol. 164 (2000) 1952-1960
103. Summersgill J.T., Raff M.J., and Miller R.D. Interactions of virulent and avirulent Legionella pneumophila with human polymorphonuclear leukocytes. Microb. Pathog. 5 (1988) 41-47
104. Teneberg S., Lönnroth I., López J.F.T., Galili U., Halvarsson M.Ö., Ångström J., and Karlsson K.A. Molecular mimicry in the recognition of glycosphingolipids by Galα3Galβ4GlcNAcβ-binding Clostridium difficile toxin A, human natural anti α-galactosyl IgG and the monoclonal antibody Gal-13: characterization of a binding-active human glycosphingolipid, non-identical with the animal receptor. Glycobiology 6 (1996) 599-609
105. Tsokos M., Schalinski S., Paulsen F., Sperhake J.P., Puschel K., and Sobottka I. Pathology of fatal traumatic and nontraumatic clostridial gas gangrene: a histopathological, immunohistochemical, and ultrastructural study of six autopsy cases. Int. J. Legal Med. 122 (2008) 35-41
106. Tucker K.D., and Wilkins T.D. Toxin A of Clostridium difficile binds to the human carbohydrate antigens I, X, and Y. Infect. Immun. 59 (1991) 73-78
107. Unligil U.M., and Rini J.M. Glycosyltransferase structure and mechanism. Curr. Opin. Struct. Biol. 10 (2000) 510-517
108. Venema R.C., Peters H.I., and Traugh J.A. Phosphorylation of elongation factor 1 (EF-1) and valyl-tRNA synthetase by protein kinase C and stimulation of EF-1 activity. J. Biol. Chem. 266 (1991) 12574-12580
109. Vetter I.R., Hofmann F., Wohlgemuth S., Herrmann C., and Just I. Structural consequences of mono-glucosylation of Ha-Ras by Clostridium sordellii lethal toxin. J. Mol. Biol. 301 (2000) 1091-1095
110. Vetter I.R., and Wittinghofer A. The guanine nucleotide-binding switch in three dimensions. Science 294 (2001) 1299-1304
111. Von Eichel-Streiber C., and Sauerborn M. Clostridium difficile toxin A carries a C-terminal repetitive structure homologous to the carbohydrate binding region of streptococcal glycosyltransferases. Gene 96 (1990) 107-113
112. Von Eichel-Streiber C., Sauerborn M., and Kuramitsu H.K. Evidence for a modular structure of the homologous repetitive C-terminal carbohydrate-binding sites of Clostridium difficile toxins and Streptcoccus mutans glucosyltransferases. J. Bacteriol. 174 (1992) 6707-6710
113. Voth D.E., and Ballard J.D. Clostridium difficile toxins: mechanism of action and role in disease. Clin. Microbiol. Rev. 18 (2005) 247-263
114. Wennerberg K., and Der C.J. Rho-family GTPases: it's not only Rac and Rho (and I like it). J. Cell Sci. 117 (2004) 1301-1312
115. Wiggins C.A.R., and Munro S. Activity of the yeast MNN1 α-1, 3-mannosyltransferase requires a motif conserved in many other families of glycosyltransferases. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 7945-7950
116. Ziegler M.O., Jank T., Aktories K., and Schulz G.E. Conformational changes and reaction of clostridial glycosylating toxins. J. Mol. Biol. 377 (2008) 1346-1356
117. Zobel-Thropp P., Yang M.C., Machado L., and Clarke S. A novel post-translational modification of yeast elongation factor 1A. Methylesterification at the C terminus. J. Biol. Chem. 275 (2000) 37150-37158
118. Zusman T., Aloni G., Halperin E., Kotzer H., Degtyar E., Feldman M., and Segal G. The response regulator PmrA is a major regulator of the icm/dot type IV secretion system in Legionella pneumophila and Coxiella burnetii. Mol. Microbiol. 63 (2007) 1508-1523